People · Operator

Alessandro E. Maselli

Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals

1
Companies
1
Filings
$650.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Catalent, Inc.PharmaceuticalsGrowth/Late$650.0M$23.6B2019
Operator network

Alessandro E. Maselli at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Gregory T. Lucier · 4 companies · 1 sharedGregory T. LucierJ. Martin Carroll · 2 companies · 1 sharedJ. Martin CarrollRolf A. Classon · 2 companies · 1 sharedRolf A. ClassonRosemary A. Crane · 2 companies · 1 sharedRosemary A. CraneChrista J. Kreuzburg · 1 companies · 1 sharedChrista J. Kreuzb…Donald E. Morel Jr. · 1 companies · 1 sharedDonald E. Morel J…Jack L. Stahl · 1 companies · 1 sharedJack L. StahlJohn J. Greisch · 1 companies · 1 sharedJohn J. GreischJohn R. Chiminski · 1 companies · 1 sharedJohn R. ChiminskiMadhavan L. Balachandran · 1 companies · 1 sharedMadhavan L. Balac…Peter E. Zippelius · 1 companies · 1 sharedPeter E. ZippeliusSteven L. Fasman · 1 companies · 1 sharedSteven L. FasmanWetteny E. Joseph · 1 companies · 1 sharedWetteny E. JosephCatalent, Inc. · $650.0M raisedCatalent, Inc.Alessandro E. MaselliAM
Alessandro E. Maselli Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Alessandro E. Maselli on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Gregory T. Lucier14
J. Martin Carroll12
Rosemary A. Crane12
Rolf A. Classon12
Madhavan L. Balachandran11
Steven L. Fasman11
John R. Chiminski11
John J. Greisch11
Christa J. Kreuzburg11
Donald E. Morel Jr.11
Peter E. Zippelius11
Wetteny E. Joseph11
Jack L. Stahl11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.

Alessandro E. Maselli — companies, boards & venture network · Provath